TKTL1 and nasopharyngeal carcinoma: Evidence implicates that the PPP is controlled by transketolase-like 1 (TKTL1) activity, and the knockdown of TKTL1 leads to a significant decrease of NADPH and ribose-5-phosphate levels in nasopharyngeal carcinoma cells [41].